Veterinary Vaccines Market to 2017 - Europe to Strengthen Its Position as the Single Largest Market for Animal Vaccines Due to Highly Organized Livestock Farms

News provided by

Jan 18, 2012, 05:43 ET

NEW YORK, Jan. 18, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Veterinary Vaccines Market to 2017 - Europe to Strengthen Its Position as the Single Largest Market for Animal Vaccines Due To Highly Organized Livestock Farms

http://www.reportlinker.com/p0761766/Veterinary-Vaccines-Market-to-2017---Europe-to-Strengthen-Its-Position-as-the-Single-Largest-Market-for-Animal-Vaccines-Due-To-Highly-Organized-Livestock-Farms.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

Veterinary Vaccines Market to 2017 - Europe to Strengthen Its Position as the Single Largest Market for Animal Vaccines Due To Highly Organized Livestock Farms

Summary Europe Europe Germany France Italy Spain Japan

GBI Research analyzes the veterinary vaccines market up to 2017. The report examines the market by analyzing livestock species including bovine, ovine, equine and porcine. The target population considered is the total animal population in each respective region. The report specifically covers livestock species excluding companion animals, and concludes that the livestock market sector has shown steady growth in recent years. Biotechnology developments and research contributed tremendously towards the growth and enhancement of the veterinary vaccines market. Europe and the US collectively hold more than 70% of the total market.

The market grew at a steady rate for the past few years and is expected to grow further. The demand for veterinary vaccines in the market is driven by factors such as the vulnerability of animals to fatal and chronic diseases, and the changing patterns of the diseases. The recent epidemics created awareness among livestock owners of the need to avoid the huge production losses due to diseases such as swine flu, avian influenza and anthrax. The future of vaccines will be dominated by DNA-related vaccines and combination vaccines, which can provide protection against various diseases with minimal vaccine shots. Such innovative products will be more capable of providing protection and generating a strong immune response than the traditional vaccines.

The key players in the veterinary vaccines market are Bayer HealthCare, Merck & Co. Inc., Fort Dodge Animal Health, Novartis Animal Heath, Pfizer, Lohmann Animal Health, Merial Ltd., Boehringer Ingelheim GmbH, and Heska Corporation. There are many other companies which are involved with the manufacturing and development of veterinary vaccines apart from those in the list.

Scope

- Annualized market data for the veterinary vaccines market from 2002 to 2010, forecast forward to 2017.- Analysis of the leading livestock segments, including bovine, ovine, porcine and equine.- Analysis of the veterinary vaccines market in the leading geographies of the world, which include the US, Europe and Japan. - Market characterization of the veterinary vaccines market, including market size, annual cost of vaccination and target population. - Key drivers and barriers that have a significant impact on the market. - Competitive benchmarking of leading companies. The key companies studied in this report are Bayer, Pfizer, Merck and Novartis.- Key M&A activities and licensing agreements that have taken place in the veterinary vaccines market.

Reasons to buy

- Align your product portfolio to the markets with high growth potential.- Develop market-entry and market expansion strategies by identifying the leading livestock segments and geographic markets poised for strong growth.- Develop key strategic initiatives by understanding the key focus areas of leading companies and niche companies which are helpful in extending the pipeline portfolio. - Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps.1 Table of Contents1 Table of Contents 31.1 List of Tables 61.2 List of Figures 82 Introduction 92.1 GBI Research Report Guidance 93 Veterinary Vaccines Market to 2017 - Market Overview 103.1 Revenue Forecasts 103.2 Drivers 113.2.1 Livestock Owners Developing Increased Disease Awareness for Farm Animals 113.3 Barriers 113.3.1 Mutant Strains of Virus Pose a Challenge in Vaccine Manufacturing 113.3.2 Decrease in Cattle Population is Reducing the Demand for Vaccines 114 Veterinary Vaccines Market to 2017 - Geographical Landscape 124.1 The US 124.1.1 Revenue Forecast 124.2 Europe 134.2.1 Revenue Forecast 134.3 Japan 144.3.1 Revenue Forecast 145 Veterinary Vaccines Market to 2017 - Bovine Vaccines Market 155.1 The US 155.1.1 Revenue Forecasts 155.1.2 Annual Cost of Vaccination 165.1.3 Target Population 175.2 Europe 185.2.1 Revenue Forecasts 185.2.2 Annual Cost of Vaccination 195.2.3 Target Population 205.3 Japan 215.3.1 Revenue Forecasts 215.3.2 Annual Cost of Vaccination 225.3.3 Target Population 236 Veterinary Vaccines Market to 2017 - Ovine Vaccines Market 246.1 The US (Sheep Vaccines Market) 246.1.1 Revenue Forecasts 246.1.2 Annual Cost of Vaccination 256.1.3 Target Population 266.2 Europe (Sheep Vaccine Market) 276.2.1 Revenue Forecasts 276.2.2 Annual Cost of Vaccination 286.2.3 Target Population 296.3 Japan (Sheep Vaccines Market) 306.3.1 Revenue Forecasts 306.3.2 Annual Cost of Vaccination 316.3.3 Target Population 326.4 The US (Goat Vaccines Market) 336.4.1 Revenue Forecasts 336.4.2 Annual Cost of Vaccination 346.4.3 Target Population 356.5 Europe (Goat Vaccines Market) 366.5.1 Revenue Forecasts 366.5.2 Annual Cost of Vaccination 376.5.3 Target Population 386.6 Japan (Goat Vaccines Market) 396.6.1 Revenue Forecasts 396.6.2 Annual Cost of Vaccination 406.6.3 Target Population 417 Veterinary Vaccines Market to 2017 - Porcine Vaccines Market 427.1 The US 427.1.1 Revenue Forecasts 427.1.2 Annual Cost of Vaccination 437.1.3 Target Population 447.2 Europe 457.2.1 Revenue Forecasts 457.2.2 Annual Cost of Vaccination 467.2.3 Target Population 477.3 Japan 487.3.1 Revenue Forecasts 487.3.2 Annual Cost of Vaccination 497.3.3 Target Population 508 Veterinary Vaccines Market to 2017 - Equine Vaccines Market 518.1 The US 518.1.1 Revenue Forecasts 518.1.2 Annual Cost of Vaccination 528.1.3 Target Population 538.2 Europe 548.2.1 Revenue Forecasts 548.2.2 Annual Cost of Vaccination 558.2.3 Target Population 568.3 Japan 578.3.1 Revenue Forecasts 578.3.2 Annual Cost of Vaccination 588.3.3 Target Population 599 Veterinary Vaccines Market to 2017 - Competitive Landscape 609.1 Company Profiles 609.1.1 Bayer HealthCare 609.1.2 Pfizer 609.1.3 Merck Inc. 629.1.4 Novartis 6310 Veterinary Vaccines Market to 2017 - Product Profiles 6410.1 Bovine Vaccines 6410.1.1 Alpha-7 6410.1.2 Vira Shield 6 + VL5 6410.1.3 Salmonella Newport Bacterial Extract SRP 6410.1.4 Imrab Large Animal 6510.1.5 Anthrax Spore Vaccine 6510.1.6 J-5 E. Coli Bacterin 6510.2 Ovine Vaccines 6610.2.1 Ultrabac 7 6610.2.2 Ultrabac CD 6610.2.3 Clostri Shield 7 6610.3 Porcine Vaccines 6710.3.1 Parvo Shield L5E 6710.3.2 Porcine Pili Shield+C 6710.3.3 LitterGuard LT-C 6710.3.4 Farrowsure Gold B 6710.4 Equine Vaccines 6810.4.1 Recombitek Equine West Nile Virus Vaccine 6810.4.2 Fluvac Innovator 6 6810.4.3 Prestige V + VEE 6810.4.4 Potomavac 6910.4.5 Imrab 3 6911 Veterinary Vaccines Market to 2017 - Mergers & Acquisitions 7011.1 Phibro Animal Health Completed Acquisition of Abic Animal Health in February 2009 7011.2 Ceva Acquired Vetech Laboratories in October 2011 7011.3 Ceva Acquired CentaurVA Animal Health in October 2011 7011.4 Harbin Pharma Acquired Pfizer's Swine Vaccine Business in June 2010 7011.5 Boehringer Ingelheim Animal Health Acquires a Significant Portion of the Fort Dodge Animal Health Business from Pfizer in October 2009 7011.6 Pfizer Acquired Microtek International in May 2010 7011.7 Virbac Acquired Certain Veterinary Products from Pfizer in February 2010 7012 Veterinary Vaccines Market to 2017 - Licensing Agreements 7112.1 Heska Corporation Amends Bovine Vaccine Agreement with AgriLabs 7112.2 Pfizer Animal Health Inks Global Licensing Deal with Epitopix 7112.3 GenVec Enters into Collaboration with Merial to Develop and Commercialize FMD Vaccine 7112.4 Vical Enters into Agreement with Japanese Partner for Veterinary Pandemic Influenza Vaccine 7113 Veterinary Vaccines Market to 2017 - Recent Activities 7213.1 Intervet's Equine West Nile Vaccine Approved by USDA (United States Department of Agriculture) 7213.2 Defra Launched Bovine Tuberculosis Vaccine 7213.3 Boehringer Ingelheim Vetmedica Receives Approval for Express FP and Express Vaccines from the USDA 7214 Veterinary Vaccines Market to 2017 - Appendix 7314.1 Market Definitions 7314.2 Abbreviations 7314.3 Research Methodology 7314.3.1 Coverage 7314.3.2 Secondary Research 7414.3.3 Primary Research 7414.4 Therapeutic Landscape 7514.4.1 Market Size by Geography 7514.5 Geographical Landscape 7514.6 Competitive Landscape 7514.6.1 Expert Panel Validation 7514.7 Contact Us 7514.8 Disclaimer 7614.9 Sources 76

1.1 List of Tables

Table 1: Veterinary Vaccines Market to 2017, Global, Revenues ($bn), 2002–2010 10Table 2: Veterinary Vaccines Market to 2017, Global, Revenue Forecast ($bn), 2010–2017 10Table 3: Veterinary Vaccines Market to 2017, The US, Revenues ($m), 2002–2010 12Table 4: Veterinary Vaccines Market to 2017, The US, Revenue Forecast ($m), 2010–2017 12Table 5: Veterinary Vaccines Market to 2017, Europe, Revenue ($m), 2002–2010 13Table 6: Veterinary Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2010–2017 13Table 7: Veterinary Vaccines Market to 2017, Japan, Revenues ($m), 2002–2010 14Table 8: Veterinary Vaccines Market to 2017, Japan, Revenue Forecast ($m), 2010–2017 14Table 9: Bovine Vaccines Market to 2017, The US, Revenue ($m), 2002–2010 15Table 10: Bovine Vaccines Market to 2017, The US, Revenue Forecast ($m), 2010–2017 15Table 11: Bovine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($),2002–2010 16Table 12: Bovine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($),2010–2017 16Table 13: Bovine Vaccines Market to 2017, The US, Target Population, (million), 2002–2010 17Table 14: Bovine Vaccines Market to 2017, The US, Target Population, (million), 2010–2017 17Table 15: Bovine Vaccines Market to 2017, Europe, Revenues ($m), 2002–2010 18Table 16: Bovine Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2010–2017 18Table 17: Bovine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002–2010 19Table 18: Bovine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2010–2017 19Table 19: Bovine Vaccines Market to 2017, Europe, Target Population, (million), 2002–2010 20Table 20: Bovine Vaccines Market to 2017, Europe, Target Population, (million), 2010–2017 20Table 21: Bovine Vaccines Market to 2017, Japan, Revenue ($m), 2002–2010 21Table 22: Bovine Vaccines Market to 2017, Japan, Revenue Forecast ($m), 2010–2017 21Table 23: Bovine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002–2010 22Table 24: Bovine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2010–2017 22Table 25: Bovine Vaccines Market to 2017, Japan, Target Population, (million), 2002–2010 23Table 26: Bovine Vaccines Market to 2017, Japan, Target Population, (million), 2010–2017 23Table 27: Sheep Vaccines Market to 2017, The US, Revenue ($m), 2002–2010 24Table 28: Sheep Vaccines Market to 2017, The US, Revenue Forecast ($m), 2010–2017 24Table 29: Sheep Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2002–2010 25Table 30: Sheep Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2010–2017 25Table 31: Sheep Vaccines Market to 2017, The US, Target Population (million), 2002–2010 26Table 32: Sheep Vaccines Market to 2017, The US, Target Population (million), 2010–2017 26Table 33: Sheep Vaccines Market to 2017, Europe, Revenue ($m), 2002–2010 27Table 34: Sheep Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2010–2017 27Table 35: Sheep Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002–2010 28Table 36: Sheep Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2010–2017 28Table 37: Sheep Vaccines Market to 2017, Europe, Target Population (million), 2002–2010 29Table 38: Sheep Vaccines Market to 2017, Europe, Target Population (million), 2010–2017 29Table 39: Sheep Vaccines Market to 2017, Japan, Revenue ($), 2002–2010 30Table 40: Sheep Vaccines Market to 2017, Japan, Revenue Forecast ($), 2010–2017 30Table 41: Sheep Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002–2010 31Table 42: Sheep Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2010–2017 31Table 43: Sheep Vaccines Market to 2017, Japan, Target Population, 2002–2010 32Table 44: Sheep Vaccines Market to 2017, Japan, Target Population, 2010–2017 32Table 45: Goat Vaccines Market to 2017, The US, Revenue ($m), 2002–2010 33Table 46: Goat Vaccines Market to 2017, The US, Revenue Forecast ($m), 2010–2017 33Table 47: Goat Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2002–2010 34Table 48: Goat Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2010–2017 34Table 49: Goat Vaccines Market to 2017, The US, Target Population (million), 2002–2010 35Table 50: Goat Vaccines Market to 2017, The US, Target Population (million), 2010–2017 35Table 51: Goat Vaccines Market to 2017, Europe, Revenue ($m), 2002–2010 36Table 52: Goat Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2010–2017 36Table 53: Goat Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002–2010 37Table 54: Goat Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2010–2017 37Table 55: Goat Vaccines Market to 2017, Europe, Target Population (million), 2002–2010 38Table 56: Goat Vaccines Market to 2017, Europe, Target Population (million), 2010–2017 38Table 57: Goat Vaccines Market to 2017, Japan, Revenue, $000's, 2002–2010 39Table 58: Goat Vaccines Market to 2017, Japan, Revenue Forecast, $000's, 2010–2017 39Table 59: Goat Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002–2010 40Table 60: Goat Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2010–2017 40Table 61: Goat Vaccines Market to 2017, Japan, Target Population, 2002–2010 41Table 62: Goat Vaccines Market to 2017, Japan, Target Population, 2010–2017 41Table 63: Porcine Vaccines Market to 2017, The US, Revenue ($m), 2002–2010 42Table 64: Porcine Vaccines Market to 2017, The US, Revenue Forecast ($m), 2010–2017 42Table 65: Porcine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2002–2010 43Table 66: Porcine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2010–2017 43Table 67: Porcine Vaccines Market to 2017, The US, Target Population (million), 2002–2010 44Table 68: Porcine Vaccines Market to 2017, The US, Target Population (million), 2010–2017 44Table 69: Porcine Vaccines Market to 2017, Europe, Revenue ($m), 2002–2010 45Table 70: Porcine Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2010–2017 45Table 71: Porcine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002–2010 46Table 72: Porcine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2010–2017 46Table 73: Porcine Vaccines Market to 2017, Europe, Target Population, (million), 2002–2010 47Table 74: Porcine Vaccines Market to 2017, Europe, Target Population, (million), 2010–2017 47Table 75: Porcine Vaccines Market to 2017, Japan, Revenue ($m), 2002–2010 48Table 76: Porcine Vaccines Market to 2017, Japan, Revenue Forecast ($m), 2010–2017 48Table 77: Porcine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002–2010 49Table 78: Porcine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2010–2017 49Table 79: Porcine Vaccines Market to 2017, Japan, Target Population (million), 2002–2010 50Table 80: Porcine Vaccines Market to 2017, Japan, Target Population (million), 2010–2017 50Table 81: Equine Vaccines Market to 2017, The US, Revenue ($m), 2002–2010 51Table 82: Equine Vaccines Market to 2017, The US, Revenue Forecast ($m), 2010–2017 51Table 83: Equine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2002–2010 52Table 84: Equine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2010–2017 52Table 85: Equine Vaccines Market to 2017, The US, Target Population (000's), 2002–2010 53Table 86: Equine Vaccines Market to 2017, The US, Target Population (000's), 2010–2017 53Table 87: Equine Vaccines Market to 2017, Europe, Revenue ($m), 2002–2010 54Table 88: Equine Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2010–2017 54Table 89: Equine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002–2010 55Table 90: Equine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2010–2017 55Table 91: Equine Vaccines Market to 2017, Europe, Target Population, 000's, 2002–2010 56Table 92: Equine Vaccines Market to 2017, Europe, Target Population, 000's, 2010–2017 56Table 93: Equine Vaccines Market to 2017, Japan, Revenue ($m), 2002–2010 57Table 94: Equine Vaccines Market to 2017, Japan, Revenue Forecast ($m), 2010–2017 57Table 95: Equine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002–2010 58Table 96: Equine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2010–2017 58Table 97: Equine Vaccines Market to 2017, Japan, Target Population, 000's, 2002–2010 59Table 98: Equine Vaccines Market to 2017, Japan, Target Population, 000's, 2010–2017 59Table 99: Veterinary Vaccines Market to 2017, Product Portfolio, Bayer HealthCare, 2011 60Table 100:Veterinary Vaccines Market to 2017, Product Portfolio, Pfizer Animal Health, 2011 61Table 101:Veterinary Vaccines Market to 2017, Product Portfolio, Merck Inc., 2011 62

1.2 List of Figures

Figure 1: Veterinary Vaccines Market to 2017, Global, Revenue Forecast ($bn), 2002–2017 10Figure 2: Veterinary Vaccines Market to 2017, The US, Revenue Forecast ($m), 2002–2017 12Figure 3: Veterinary Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2002–2017 13Figure 4: Veterinary Vaccines Market to 2017, Japan, Revenue Forecast ($m), 2002–2017 14Figure 5: Bovine Vaccines Market to 2017, The US, Revenue Forecast ($m), 2002–2017 15Figure 6: Bovine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($),2002–2017 16Figure 7: Bovine Vaccines Market to 2017, The US, Target Population, (million), 2002–2017 17Figure 8: Bovine Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2002–2017 18Figure 9: Bovine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002–2017 19Figure 10: Bovine Vaccines Market to 2017, Europe, Target Population, (million), 2002–2017 20Figure 11: Bovine Vaccines Market to 2017, Japan, Revenue Forecast ($m), 2002–2017 21Figure 12: Bovine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($),2002–2017 22Figure 13: Bovine Vaccines Market to 2017, Japan, Target Population, (million), 2002–2017 23Figure 14: Sheep Vaccines Market to 2017, The US, Revenue Forecast ($m), 2002–2017 24Figure 15: Sheep Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2002–2017 25Figure 16: Sheep Vaccines Market to 2017, The US, Target Population (million), 2002–2017 26Figure 17: Sheep Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2002–2017 27Figure 18: Sheep Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002–2017 28Figure 19: Sheep Vaccines Market to 2017, Europe, Target Population (million), 2002–2017 29Figure 20: Sheep Vaccines Market to 2017, Japan, Revenue Forecast ($), 2002–2017 30Figure 21: Sheep Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002–2017 31Figure 22: Sheep Vaccines Market to 2017, Japan, Target Population, 2002–2017 32Figure 23: Goat Vaccines Market to 2017, The US, Revenue Forecast ($m), 2002–2017 33Figure 24: Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2002–2017 34Figure 25: Goat Vaccines Market to 2017, The US, Target Population (million), 2002–2017 35Figure 26: Goat Vaccines Market to 2017, Europe, Revenue ($m), 2002–2017 36Figure 27: Goat Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002–2017 37Figure 28: Goat Vaccines Market to 2017, Europe, Target Population (million), 2002–2017 38Figure 29: Goat Vaccines Market to 2017, Japan, Revenue Forecast, $000's, 2002–2017 39Figure 30: Goat Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002–2017 40Figure 31: Goat Vaccines Market to 2017, Japan, Target Population, 2002–2017 41Figure 32: Porcine Vaccines Market to 2017, The US, Revenue Forecast ($m), 2002–2017 42Figure 33: Porcine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2002–2017 43Figure 34: Porcine Vaccines Market to 2017, The US, Target Population (million), 2002–2017 44Figure 35: Porcine Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2002–2017 45Figure 36: Porcine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002–2017 46Figure 37: Porcine Vaccines Market to 2017, Europe, Target Population, (million), 2002–2017 47Figure 38: Porcine Vaccines Market to 2017, Japan, Revenue ($m), 2002–2017 48Figure 39: Porcine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002–2017 49Figure 40: Porcine Vaccines Market to 2017, Japan, Target Population (million), 2002–2017 50Figure 41: Equine Vaccines Market to 2017, The US, Revenue Forecast ($m), 2002–2017 51Figure 42: Equine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2002–2017 52Figure 43: Equine Vaccines Market to 2017, The US, Target Population (000's), 2002–2017 53Figure 44: Equine Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2002–2017 54Figure 45: Equine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002–2017 55Figure 46: Equine Vaccines Market to 2017, Europe, Target Population, 000's, 2002–2017 56Figure 47: Equine Vaccines Market to 2017, Japan, Revenue Forecast ($m), 2002–2017 57Figure 48: Equine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002-2017 58Figure 49: Equine Vaccines Market to 2017, Japan, Target Population, 000's, 2002–2017 59